Abstract
Objective
To investigate the role of diabetes as risk factor for ICU-acquired bloodstream infections (BSI).
Design
Prospective observational study.
Setting
A general eight-bed ICU of a tertiary hospital.
Patients
Three hundred and forty-three consecutive patients (63 diabetic and 280 nondiabetic) admitted in the ICU.
Methods
BSI episodes in the ICU were recorded and classified as primary, secondary, catheter-related and mixed according to strict criteria. In all patients, blood glucose was strictly controlled with a continuous insulin infusion within a range of 80–120 mg/dl.
Results
One-hundred and eighteen patients (34.4%) developed at least one BSI episode. Diabetic patients had an increased probability of developing at least one BSI episode compared with nondiabetic patients (hazard ratio = 1.66, 95% confidence interval 1.04–2.64, P = 0.034) in a Cox proportional hazards regression model adjusting for age, gender, admission category and APACHE II score at admission in the ICU and comorbidities.
Conclusions
Despite strict glycemic control, diabetic patients have a 1.7-fold probability of developing an ICU-acquired BSI compared to nondiabetic subjects.
Similar content being viewed by others
References
Vallés J, León C, Álvarez-Lerma F (1997) Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. The Spanish Collaborative Group for Infection in Intensive Care Unit of SEMIUC. Clin Infect Dis 24:387–395
Pittet D, Tarata D, Wenzel RP (1994) Nosocomial bloodstream infections in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601
Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. Am J Resp Crit Care Med 163:1584–1590
Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32:992–997
Chi CY, Wong WW, Fung CP, Yu KW, Liu CY (2004) Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect 37:16–23
Bader MS, Lai SM, Kumar V, Hinthorn D (2004) Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality. Scand J Infect Dis 36:860–864
Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO (1994) Bloodstream infections at a Norwegian university hospital, 1974–1979 and 1988–1989: changing etiology, clinical features, and outcome. Clin Infect Dis 19:246–256
Kreisel K, Boyd K, Langenberg P, Roghmann MC (2006) Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis 55:179–184
Lin YC, Chen TL, Ju HL, Chen HS, Wang FD, Yu KW, Liu CY (2006) Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia. J Microbiol Immunol Infect 39:67–72
Thomsen RW, Hundborg HH, Lervang H-H, Johnsen SP, Schønheyder HC, Sørensen HT (2005) Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to Enterobacteria: a 10-year population-based study among adults. Clin Infect Dis 40:628–631
Ryan T, Carthy J, Rady M, Serkey J, Gordon S, Starr NJ, Cosgrove D (1997) Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med 25:2009–2014
Sreeramoju PV, Tolentino J, Garcia-Houchins S, Weber SG (2008) Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery. Infect Control Hosp Epidemiol 29:51–56
Damas P, Ledoux D, Nys M, Monchi M, Wiesen P, Beauve B, Preiser J-C (2008) Intensive care unit acquired infection and organ failure. Intensive Care Med 34:856–864
Michalia M, Kompoti M, Panagiotakopoulou A, Romanou V, Paridou A, Koutsikou A, Clouva-Molyvdas M (2007) Diabetes mellitus is an independent risk factor for bloodstream infections in critically ill patients (abstract no. 620). Intensive Care Med 33(Suppl 2):S160
Charlson ME, Pompei P, Ales KL, MacKenzie RC (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) International Sepsis Definitions Conference 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538
Hosmer DW, Lemeshow S (1999) Model development. In: Applied survival analysis: regression modelling of time to event data. Wiley, New York, pp 158–195. ISBN 0-471-15410-5
Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912
Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT (2004) Risk of community-acquired pneumococcal bacteremia in patients with diabetes mellitus: a population-based case–control study. Diabetes Care 27:1143–1147
Lin JC, Siu LK, Fung CP, Tsou HH, Wang JJ, Chen CT, Wang SC, Chang FY (2006) Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab 91:3084–3087
Alba-Loureiro TC, Hirabara SM, Mendonça JR, Curi R, Pithon-Curi TC (2006) Diabetes causes marked changes in function and metabolism of rat neutrophils. J Endocrinol 188:295–303
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367
Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461
Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouchaert B, Bruyninckx F, Bouillon R, Schetz M (2006) Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55:3151–3159
Honiden S, Schultz A, Im SA, Nierman DM, Gong MN (2008) Early versus late intravenous insulin administration in critically ill patients. Intensive Care Med 34:881–887
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 34:17–60
Conflict of interest statement
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michalia, M., Kompoti, M., Koutsikou, A. et al. Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med 35, 448–454 (2009). https://doi.org/10.1007/s00134-008-1288-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-008-1288-0